Biomarker and imaging responses to spironolactone in subclinical diabetic cardiomyopathy.
暂无分享,去创建一个
T. Marwick | Jeremy T. Wright | J. Sacre | C. Jellis | C. Jenkins | Jennifer H. Martin | B. Haluska | L. Jeffriess
[1] A. Pasipoularides. Evaluation of Right and Left Ventricular Diastolic Filling , 2013, Journal of Cardiovascular Translational Research.
[2] Andrew S Flett,et al. Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease , 2012, Heart.
[3] P. Kellman,et al. Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology. , 2012, European heart journal.
[4] T. Marwick,et al. A randomized study of the beneficial effects of aldosterone antagonism on LV function, structure, and fibrosis markers in metabolic syndrome. , 2011, JACC. Cardiovascular imaging.
[5] Titus Kuehne,et al. Assessment of Diffuse Myocardial Fibrosis in Rats Using Small-Animal Look-Locker Inversion Recovery T1 Mapping , 2011, Circulation. Cardiovascular imaging.
[6] Jeremy T. Wright,et al. Association of Imaging Markers of Myocardial Fibrosis With Metabolic and Functional Disturbances in Early Diabetic Cardiomyopathy , 2011, Circulation. Cardiovascular imaging.
[7] A. Jenkins,et al. Impact of type 2 diabetes and the metabolic syndrome on myocardial structure and microvasculature of men with coronary artery disease , 2011, Cardiovascular diabetology.
[8] A. di Lenarda,et al. Predictors of early-stage left ventricular dysfunction in type 2 diabetes: results of DYDA study , 2011, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
[9] C. Jellis,et al. Usefulness of at rest and exercise hemodynamics to detect subclinical myocardial disease in type 2 diabetes mellitus. , 2011, The American journal of cardiology.
[10] P. Steendijk,et al. Cardiac Inflammation Contributes to Changes in the Extracellular Matrix in Patients With Heart Failure and Normal Ejection Fraction , 2011, Circulation. Heart failure.
[11] C. Jellis,et al. Reduced End-Systolic Pressure-Volume Ratio Response to Exercise: A Marker of Subclinical Myocardial Disease in Type 2 Diabetes , 2010, Circulation. Cardiovascular imaging.
[12] Petra C. Kienesberger,et al. Shedding light on the enigma of myocardial lipotoxicity: the involvement of known and putative regulators of fatty acid storage and mobilization. , 2010, American journal of physiology. Endocrinology and metabolism.
[13] D. Moher,et al. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomized trials , 2010, Obstetrics and gynecology.
[14] D. Moher,et al. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials , 2010, Journal of clinical epidemiology.
[15] Johan Verjans,et al. Myocardial remodeling after infarction: the role of myofibroblasts , 2010, Nature Reviews Cardiology.
[16] U. Eriksson,et al. Mechanisms of cardiac fibrosis in inflammatory heart disease. , 2009, Trends in cardiovascular medicine.
[17] Shi-Yan Li,et al. Advanced glycation endproduct (AGE) accumulation and AGE receptor (RAGE) up‐regulation contribute to the onset of diabetic cardiomyopathy , 2009, Journal of cellular and molecular medicine.
[18] B. Pitt,et al. Extracellular Cardiac Matrix Biomarkers in Patients With Acute Myocardial Infarction Complicated by Left Ventricular Dysfunction and Heart Failure: Insights From the Eplerenone Post–Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) Study , 2009, Circulation.
[19] M. Volpe,et al. Role of the renin-angiotensin-aldosterone system and inflammatory processes in the development and progression of diastolic dysfunction. , 2009, Clinical science.
[20] S. Donnelly,et al. Diagnosis of heart failure with preserved ejection fraction: improved accuracy with the use of markers of collagen turnover , 2009, European journal of heart failure.
[21] Arturo Evangelista,et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. , 2009, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[22] F. Flachskampf,et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. , 2008, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.
[23] Thomas H. Marwick,et al. Myocardial Imaging: Tissue Doppler and Speckle Tracking , 2009 .
[24] Sandeep N. Gupta,et al. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. , 2008, Journal of the American College of Cardiology.
[25] D. Celermajer,et al. Diastolic dysfunction and abnormalities of the microcirculation in type 2 diabetes , 2008, Diabetes, obesity & metabolism.
[26] James D. Thomas,et al. Designation of Tissue Doppler Normal Range , 2008 .
[27] T. Marwick,et al. Performance of conventional echocardiographic parameters and myocardial measurements in the sequential evaluation of left ventricular function. , 2008, The American journal of cardiology.
[28] S. Robins. Biochemistry and functional significance of collagen cross-linking. , 2007, Biochemical Society transactions.
[29] W. Piwowarska,et al. Diabetes-specific cardiomyopathy in type 1 diabetes mellitus: no evidence for its occurrence in the era of intensive insulin therapy. , 2007, European heart journal.
[30] J. Sanderson,et al. Aldosterone receptor antagonism induces reverse remodeling when added to angiotensin receptor blockade in chronic heart failure. , 2007, Journal of the American College of Cardiology.
[31] J. Díez,et al. Mechanisms of Cardiac Fibrosis in Hypertension , 2007, Journal of clinical hypertension.
[32] A. Støylen,et al. Automated analysis of myocardial deformation at dobutamine stress echocardiography: an angiographic validation. , 2007, Journal of the American College of Cardiology.
[33] E. Colín-Ramírez,et al. Aldosterone receptor antagonists induce favorable cardiac remodeling in diastolic heart failure patients. , 2007, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion.
[34] Kenneth McDonald,et al. Diastolic Heart Failure: Evidence of Increased Myocardial Collagen Turnover Linked to Diastolic Dysfunction , 2007, Circulation.
[35] T. Marwick,et al. Obesity cardiomyopathy: pathogenesis and pathophysiology , 2007, Nature Clinical Practice Cardiovascular Medicine.
[36] Wolfgang A Linke,et al. Myocardial Structure and Function Differ in Systolic and Diastolic Heart Failure , 2006, Circulation.
[37] F. Alla,et al. Early changes in serum markers of cardiac extra‐cellular matrix turnover in patients with uncomplicated hypertension and type II diabetes , 2006, European journal of heart failure.
[38] T. Marwick,et al. Diabetic heart disease. , 2006, Heart.
[39] T. Marwick,et al. Determinants of subclinical diabetic heart disease , 2005, Diabetologia.
[40] T. Marwick,et al. Effect of Aldosterone Antagonism on Myocardial Dysfunction in Hypertensive Patients With Diastolic Heart Failure , 2004, Circulation.
[41] R. Turner,et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.
[42] B. Pitt,et al. Eplerenone , a Selective Aldosterone Blocker , in Patients with Left Ventricular Dysfunction after Myocardial Infarction , 2003 .
[43] Arantxa González,et al. Losartan-Dependent Regression of Myocardial Fibrosis Is Associated With Reduction of Left Ventricular Chamber Stiffness in Hypertensive Patients , 2002, Circulation.
[44] Arantxa González,et al. Usefulness of Serum Carboxy-Terminal Propeptide of Procollagen Type I in Assessment of the Cardioreparative Ability of Antihypertensive Treatment in Hypertensive Patients , 2001, Circulation.
[45] F. Alla,et al. Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure: Insights From the Randomized Aldactone Evaluation Study (RALES) , 2000, Circulation.
[46] S. Ommen,et al. Clinical Utility of Doppler Echocardiography and Tissue Doppler Imaging in the Estimation of Left Ventricular Filling Pressures: A Comparative Simultaneous Doppler-Catheterization Study , 2000, Circulation.
[47] B. Pitt,et al. The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure , 2000 .
[48] J. Emparanza,et al. Serum carboxy-terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease. , 2000, Circulation.
[49] B. Pitt,et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. , 1999, The New England journal of medicine.
[50] K. Weber. Aldosterone and spironolactone in heart failure. , 1999, The New England journal of medicine.
[51] Mario J. Garcia,et al. Tissue Doppler to Assess Diastolic Left Ventricular Function , 1999, Echocardiography.
[52] A. Ciampi,et al. Two-year time course and significance of neurohumoral activation in the Survival and Ventricular Enlargement (SAVE) Study. , 1998, European heart journal.
[53] H. Eichler,et al. Measuring extracellular matrix turnover in the serum of patients with idiopathic or ischemic dilated cardiomyopathy and impact on diagnosis and prognosis. , 1995, The American journal of cardiology.
[54] M. Shimizu,et al. Collagen remodelling in myocardia of patients with diabetes. , 1993, Journal of clinical pathology.
[55] S. Daniels,et al. Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. , 1992, Journal of the American College of Cardiology.
[56] K. Weber,et al. Pathological Hypertrophy and Cardiac Interstitium: Fibrosis and Renin‐Angiotensin‐Aldosterone System , 1991, Circulation.
[57] K. Swedberg,et al. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group. , 1990, Circulation.
[58] E Picano,et al. In vivo quantitative ultrasonic evaluation of myocardial fibrosis in humans. , 1990, Circulation.
[59] P. Toft,et al. Serum aminoterminal type III procollagen peptide reflects repair after acute myocardial infarction. , 1990, Circulation.
[60] E. Olsen,et al. Pathology of hypertrophic cardiomyopathy. , 1986, Postgraduate medical journal.